Blood-Brain Barrier Disruption and Perivascular Beta-Amyloid Accumulation in the Brain of Aged Rats with Spontaneous Hypertension: Evaluation with Dynamic Contrast-Enhanced Magnetic Resonance Imaging

다국어 초록 (Multilingual Abstract)

Objective: Whether blood-brain barrier (BBB) disruption induced by chronic spontaneous hypertension is associated with beta-amyloid (Aβ) accumulation in the brain remains poorly understood. The purpose of this study was to investigate the relationship between BBB disruption and Aβ influx and accumulation in the brain of aged rats with chronic spontaneous hypertension.
Materials and Methods: Five aged spontaneously hypertensive rats (SHRs) and five age-matched normotensive Wistar-Kyoto (WKY) rats were studied. The volume transfer constant (Ktrans) obtained from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) was used to evaluate BBB permeability in the hippocampus and cortex in vivo. The BBB tight junctions, immunoglobulin G (IgG), Aβ, and amyloid precursor protein (APP) in the hippocampus and cortex were examined with immunohistochemistry.
Results: As compared with WKY rats, the Ktrans values in the hippocampus and cortex of the SHRs increased remarkably (0.316 ± 0.027 min-1 vs. 0.084 ± 0.017 min-1, p < 0.001 for hippocampus; 0.302 ± 0.072 min-1 vs. 0.052 ± 0.047 min-1, p < 0.001 for cortex). Dramatic occludin and zonula occludens-1 losses were detected in the hippocampus and cortex of SHRs, and obvious IgG exudation was found there. Dramatic Aβ accumulation was found and limited to the area surrounding the BBB, without extension to other parenchyma regions in the hippocampus and cortex of aged SHRs. Alternatively, differences in APP expression in the hippocampus and cortex were not significant.
Conclusion: Blood-brain barrier disruption is associated with Aβ influx and accumulation in the brain of aged rats with chronic spontaneous hypertension. DCE-MRI can be used as an effective method to investigated BBB damage.

참고문헌 (Reference)

1 Wolburg H, "Tight junctions of the blood-brain barrier: development, composition and regulation" 38 : 323-337, 2002

2 Paxinos G, "The rat brain in stereotaxic coordinates, 6th ed" Elsevier Academic Press 273-275, 2007

3 Hawkins BT, "The blood-brain barrier/neurovascular unit in health and disease" 57 : 173-185, 2005

4 Zlokovic BV, "The blood-brain barrier in health and chronic neurodegenerative disorders" 57 : 178-201, 2008

5 Hardy J, "The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics" 297 : 353-356, 2002

6 Csiszar A, "Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in $\beta$-amyloid generation and Alzheimer's disease" 305 : H1120-H1130, 2013

7 Pelisch N, "RAS inhibition attenuates cognitive impairment by reducing blood- brain barrier permeability in hypertensive subjects" 9 : 93-98, 2013

8 Deane R, "RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain" 9 : 907-913, 2003

9 Zhang H, "Proteolytic processing of Alzheimer's $\beta$-amyloid precursor protein" 120 (120): 9-21, 2012

10 Bell RD, "Neurovascular mechanisms and bloodbrain barrier disorder in Alzheimer's disease" 118 : 103-113, 2009

11 Aksoy D, "Magnetic resonance imaging profile of blood-brain barrier injury in patients with acute intracerebral hemorrhage" 2 : e000161-, 2013

12 Schreiber S, "Interplay between age, cerebral small vessel disease, parenchymal amyloid-$\beta$, and tau pathology: longitudinal studies in hypertensive stroke-prone rats" 42 (42): S205-S215, 2014

13 Nag S, "Immunohistochemical detection of endothelial proteins" 89 : 489-501, 2003

14 Carnevale D, "Hypertension induces brain $\beta$-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature" 60 : 188-197, 2012

15 Faraco G, "Hypertension enhances $A{\beta}$-induced neurovascular dysfunction, promotes $\beta$-secretase activity, and leads to amyloidogenic processing of APP" 36 : 241-252, 2016

16 Bueche CZ, "Hypertension drives parenchymal $\beta$-amyloid accumulation in the brain parenchyma" 1 : 124-129, 2014

17 Bhatia R, "Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity" 14 : 1233-1243, 2000

18 Tofts PS, "Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols" 10 : 223-232, 1999

19 Obermeier B, "Development, maintenance and disruption of the blood-brain barrier" 19 : 1584-1596, 2013

20 Ortuno JE, "DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data" 14 : 316-, 2013

21 Bailey EL, "Cerebral small vessel endothelial structural changes predate hypertension in stroke-prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5- to 21-week-old rats" 37 : 711-726, 2011

22 Ueno M, "Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats" 107 : 532-538, 2004

23 Montagne A, "Blood-brain barrier breakdown in the aging human hippocampus" 85 : 296-302, 2015

24 Gentile MT, "Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension" 30 : 222-228, 2009

25 Hofman A, "Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study" 349 : 151-154, 1997

26 Heye AK, "Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review" 6 : 262-274, 2014

27 Nicolas M, "Amyloid precursor protein and neural development" 141 : 2543-2548, 2014

28 Wang W, "Amyloid precursor protein ${\alpha}$- and $\beta$-cleaved ectodomains exert opposing control of cholesterol homeostasis via SREBP2" 28 : 849-860, 2014

29 Miners JS, "Abeta-degrading enzymes in Alzheimer's disease" 18 : 240-252, 2008